Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

CLSD Articles Clearside Biomedical Inc.

home / stock / clsd / clsd articles

CLSD CLSD Quote CLSD Short CLSD News CLSD Articles CLSD Message Board

Articles | Clearside Biomedical Inc. (NASDAQ:CLSD)

  • Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery | Benzinga

    - Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachor...

    • June 27, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Why Is Clearside Biomedical Stock Gaining Today? | Benzinga

    Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back o...

    • June 25, 2024 04:54:36 pm
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® | Benzinga

    - Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Curren...

    • May 21, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference | Benzinga

    ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the del...

    • May 08, 2024 08:15:00 pm
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 | Benzinga

    ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

    • April 30, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Expensify And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

    The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aro...

    • April 22, 2024 11:38:09 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors | Benzinga

    ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

    • April 16, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference | Benzinga

    ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

    • April 02, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
  • Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | Benzinga

    ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

    • March 18, 2024 11:05:00 am
    • |
    • Benzinga
    • |
      • CLSD Stock
      • CLSD Quote
      • CLSD Short
      • CLSD News
      • CLSD Articles
      • CLSD Message Board
Next 10
Stock Information
Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...

Clearside Biomedical Inc. Company Name:

CLSD Stock Symbol:

NASDAQ Market:

-0.84% G/L:

$0.8445 Last:

46,154 Volume:

$0.84 Open:

$0.8445 Close:

Clearside Biomedical Inc. Website:

Clearside Biomedical Inc. Logo

Ad

Investor Relations
RECENT CLSD NEWS
  • CLSD - Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

    ALPHARETTA, Ga., April 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that George Lasezkay, PharmD, JD, Pr...

  • CLSD - Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

    - Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS ® (XIPERE ® ) for Uveitic Macular Edema Accepted for Regulatory Review in China - -...

  • CLSD - Expected US Company Earnings on Thursday, March 27th, 2025

    HG Holdings Inc (STLY) is expected to report for quarter end 2024-12-31 Savara Inc. (SVRA) is expected to report $-0.11 for Q4 2024 Reborn Coffee Inc. (REBN) is expected to report for quarter end 2024-12-31 VSee Health Inc. (VSEE) is expected to report for Q4 2024 IceCure Medical ...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get CLSD Alerts

Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1